Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Vantictumab

Vantictumab (OMP-18R5) is a humanized anti-FZD1/2/5/7/8 monoclonal antibody that inhibits Wnt pathway signaling and is used in research studies for the treatment of metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.

Product Specifications

CAS Number

1345009-45-1

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Wnt/beta-catenin

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Olr693 Protein Vector (Rat) (pPB-N-His)
PV290835 500 ng

Olr693 Protein Vector (Rat) (pPB-N-His)

Sign In for Pricing
View Details
Hsa-miR-126-3p miRNA Antagomir
CIJ0118-01 10 nmol

Hsa-miR-126-3p miRNA Antagomir

Sign In for Pricing
View Details
Hsa-miR-126-3p miRNA Antagomir
CIJ0118-02 20 nmol

Hsa-miR-126-3p miRNA Antagomir

Sign In for Pricing
View Details
CCND3 (Phospho-S264) Blocking peptide
orb1441137 500 µg

CCND3 (Phospho-S264) Blocking peptide

Sign In for Pricing
View Details
HMGB1 (High Mobility Group Protein 1, HMG-1, High Mobility Group Protein B1, High-mobility Group Box 1, HMGB1, DKFZp686A04236, HMG3, SBP-1) discontinued
H6202-01D 50 µg

HMGB1 (High Mobility Group Protein 1, HMG-1, High Mobility Group Protein B1, High-mobility Group Box 1, HMGB1, DKFZp686A04236, HMG3, SBP-1) discontinued

Sign In for Pricing
View Details
Claudin 8 (CLDN8) (FITC) discontinued
C5838-56A-FITC 100 µL

Claudin 8 (CLDN8) (FITC) discontinued

Sign In for Pricing
View Details